复发性脑胶质瘤的临床治疗进展  

Advances in the clinical treatment of recurrent glioma

作　　者：连露露 范小璇 赵晓平 张志刚[1] 司泽钰 封玉宁 林隆杰 王凯 LIAN Lu-Lu;FAN Xiao-Xuan;ZHAO Xiao-Ping;ZHANG Zhi-Gang;SI Ze-Yu;FENG Yu-Ning;LIN Long Jie;WANG Kai(The first Clinical Medical College of Shaanxi University of Chinese Medicine,Xianyang,Shaanxi 712046,China;Department of Neurosurgery,Affiliated Hospital of Shaanxi University of Chinese Medicine/Shaanxi Clinical Research Cen-ter of TCM Encephalopathy,Xianyang,Shaanxi 712046,China;Department of neurology,Ankang Hospital of Traditional Chinese Medicine,Ankang,Shaanxi 735000,China)

机构地区：[1]陕西中医药大学第一临床医学院,陕西咸阳712046 [2]陕西中医药大学附属医院脑外科/陕西省中医脑病临床医学研究中心,陕西咸阳712046 [3]安康市中医医院脑病科,陕西安康735000

出　　处：《国际神经病学神经外科学杂志》2022年第2期84-88,共5页Journal of International Neurology and Neurosurgery

基　　金：陕西省省级院士工作站建设项目(2019-30);陕西省中西医结合临床协作创新项目(2020-ZXY-007)。

摘　　要：脑胶质瘤是最常见的中枢神经系统恶性肿瘤,大多数脑胶质瘤患者在接受标准疗法治疗后都会复发。目前尚没有复发性脑胶质瘤治疗的标准及共识,该文就复发性脑胶质瘤的临床治疗进展进行综述。Glioma is the most common malignant tumor of the central nervous system,and most patients with glioma will experience recurrence after receiving standard therapy.Currently,there is still no standard or consensus on the treatment of recurrent glioma.This article reviews the advances in the clinical treatment of recurrent glioma.

关 键 词：脑胶质瘤 放射治疗 化学治疗 靶向治疗 免疫治疗 

分 类 号：R739.41[医药卫生—肿瘤]